On today’s episode, meet Biljana Naumovic. Biljana is the President of U.S. Oncology, Solid Tumor at Johnson & Johnson, where she is spearheading innovative cancer treatments and advocating for equity in healthcare. She is committed to advancing the organization’s solid tumor portfolio and pipeline, spanning prostate, bladder, and lung cancer, as well as multiple novel treatment pathways. Biljana is passionately focused on bringing medical innovation&n...
Show more...